Abstract
In a time of overeagerness toward the use of prescription medications to treat diseases and symptoms, of which benign prostatic hyperplasia (BPH) and nocturia are not exempt, it is easy to disregard or minimize the importance that lifestyle changes can play in overall management. Indeed, for patients who have mild symptoms that are not particularly bothersome, such behavioral modification may be preferable in view of its general safety and the perception of cost-effectiveness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
IPSS/AUASI: validated seven questions on urgency, daytime and nighttime urinary frequency, hesitancy, intermittency, sensation of incomplete voiding, and force of urine stream.
References
Lowe FC, Fagelman E. Phytotherapy in the treatment of benign prostatic hyperplasia: an update. Urology. 1999;53(4):671–8.
Bales GT, Christiano AP, Kirsh EJ, Gerber GS. Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology. 1999;54(1):86–9.
Buck AC. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol. 2004;172(5 Pt 1):1792–9.
Levin RM, Hass MA, Bellamy F, Horan P, Whitbeck K, Chow PH, et al. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction. J Urol. 2002;167(5):2253–9.
Levin RM, Whitbeck C, Horan P, Bellamy F. Low-dose tadenan protects the rabbit bladder from bilateral ischemia/reperfusion-induced contractile dysfunction. Phytomedicine. 2005;12(1–2):17–24.
Feifer AH, Fleshner NE, Klotz L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol. 2002;168(1):150–4. discussion 4.
Habib FK, Wyllie MG. Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer Prostatic Dis. 2004;7(3):195–200.
Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA. 1998;280(18):1604–9.
Boyle P, Robertson C, Lowe F, Roehrborn C. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004;93(6):751–6.
Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. BJU Int. 2003;92(3):267–70.
Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354(6):557–66.
Tacklind J, MacDonald R, Rutks I, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2009;15(2):CD001423.
Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med. 2000;109(8):654–64.
Carraro JC, Raynaud JP, Koch G, Chisholm GD, Di Silverio F, Teillac P, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate. 1996;29(4):231–40. discussion 41–2.
Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, et al. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Prog Urol. 2002;12(3):384–92. discussion 94–4.
Debruyne F, Boyle P, Calais Da Silva F, Gillenwater JG, Hamdy FC, Perrin P, et al. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. Eur Urol. 2004;45(6):773–9. discussion 9–80.
Hizli F, Uygur MC. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia. Int Urol Nephrol. 2007;39(3):879–86.
Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, et al. A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008;16(3):147–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tu, D.D., Lowe, F.C. (2012). Nocturia: Treatment with Alternative Therapies. In: Weiss, MD, FACS, J., Blaivas, MD, J., Van Kerrebroeck, MD, PhD, MMSc, P., Wein, MD, FACS, PhD(hon), A. (eds) Nocturia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1156-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1156-7_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1155-0
Online ISBN: 978-1-4614-1156-7
eBook Packages: MedicineMedicine (R0)